Ziyuan (Constance) Zhang
Lawyers
Filters
Elevance Health $5.2 billion senior notes offering
The investment-grade notes are due 2026, 2030, 2031, 2035, 2055 and 2064
Amberjack Capital Partners secondary transaction and formation of continuation fund
This transaction marks the third time we have advised Amberjack on a GP-led secondary transaction and continuation fund formation
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Elevance Health $2.6 billion senior notes offering
The investment-grade notes are due 2029, 2034 and 2054
White Deer GP-led secondary transaction and formation of continuation fund
We advised White Deer on the secondary transaction and $240 million continuation fund formation
TPG $600 million senior notes offering
We advised TPG on its investment-grade notes offering
TPG $400 million debut notes offering
We advised TPG on its inaugural offering of junior subordinated notes
Delinea acquisition of Fastpath Solutions
We are advising Delinea on the acquisition
Camin Cargo Control sale to Macquarie Group
We advised Camin Cargo Control and Metalmark Capital on the transaction
Gran Tierra Energy exchange offer and consent solicitations
The exchange offer included the issuance of new senior secured notes due 2029